Dr. Singhal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
Weill Cornell MedicineClass of 2018, MD/PhD
Certifications & Licensure
NJ State Medical License 2024 - 2025
NY State Medical License 2020 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsA Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer.Anupriya Singhal, Hannah C Styers, Jonathan Rub, Zhuxuan Li, Stefan R Torborg
Cancer Discovery. 2024-11-01 - Adjuvant Modified FOLFIRINOX for Resected Pancreatic Adenocarcinoma (PDAC): Clinical Insights and Genomic Features from a Large Contemporary Cohort.Fergus Keane, Catherine O'Connor, Drew Moss, Joanne F Chou, Maria A Perry
Journal of the National Cancer Institute. 2024-10-26 - 1 citationsPrecision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease.Fergus Keane, Joanne F Chou, Henry Walch, Joshua Schoenfeld, Anupriya Singhal
Journal of the National Cancer Institute. 2024-09-01
Press Mentions
MSK Discovery Suggests Opportunity to Improve Effectiveness of KRAS Inhibitors Against Pancreatic CancerJuly 11th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
